Within Grey Area: Patents, Pharmaceuticals, and Genomics
... many risks associated with their industry. Another important part of the drug industry appears to be that in the past few decades the pharmaceutical industry has shifted its focus. With the high costs and large amount of time spent on clinical trials many focus on developing drugs for chronic diseas ...
... many risks associated with their industry. Another important part of the drug industry appears to be that in the past few decades the pharmaceutical industry has shifted its focus. With the high costs and large amount of time spent on clinical trials many focus on developing drugs for chronic diseas ...
European Perspective - Society of Nuclear Medicine
... indications – only GRP • Licensed products used ouside authorised indications – in some countries simpler submission ...
... indications – only GRP • Licensed products used ouside authorised indications – in some countries simpler submission ...
Botanical Substances in Western Medicine
... • In 1994, congress passed the Dietary Supplement Health and Education Act (DSHEA), which essentially de-regulated the sale of herbal medicines in the US by recasting them as “dietary supplements” • Removes herbs from strict FDA regulations placed on drugs, as long as they do not claim any medically ...
... • In 1994, congress passed the Dietary Supplement Health and Education Act (DSHEA), which essentially de-regulated the sale of herbal medicines in the US by recasting them as “dietary supplements” • Removes herbs from strict FDA regulations placed on drugs, as long as they do not claim any medically ...
ProArgi-9
... safely used in humans since 1983. Dr. Allen received the first glycemic patent ever awarded for her development of the low glycemic delivery system in ProArgi-9. The methodology developed exclusively for ProArgi-9 is proprietary, and involves a complex 32-step process to extract the non-competing pro ...
... safely used in humans since 1983. Dr. Allen received the first glycemic patent ever awarded for her development of the low glycemic delivery system in ProArgi-9. The methodology developed exclusively for ProArgi-9 is proprietary, and involves a complex 32-step process to extract the non-competing pro ...
Destroying Schedule 4 Controlled Drugs (CDs)
... security’. There is however an exception - any dose of a controlled drug that is prepared but not administered, including odd doses spat out by the patient must be destroyed on the ward or department immediately. Though CDs are usually destroyed in a DOOP kit, these single doses can be disposed of i ...
... security’. There is however an exception - any dose of a controlled drug that is prepared but not administered, including odd doses spat out by the patient must be destroyed on the ward or department immediately. Though CDs are usually destroyed in a DOOP kit, these single doses can be disposed of i ...
Recent changes have been introduced to the Summary of Product
... specified controlled drug in the body, in excess of a specified limit (Section 5A of the Road Traffic Act 1988 as amended in April 2013). The drugs to be covered by this offence are defined in regulations supporting the offence and are listed below. Those individuals who have taken their medicine(s) ...
... specified controlled drug in the body, in excess of a specified limit (Section 5A of the Road Traffic Act 1988 as amended in April 2013). The drugs to be covered by this offence are defined in regulations supporting the offence and are listed below. Those individuals who have taken their medicine(s) ...
UNIVERSITY OF KENTUCKY
... Declared botanical products cannot be removed from the market if they make no health claims and are not proven unsafe * Burden of proof of safety lies with FDA, not manufacturer (unlike prescription drugs) Determined herbal products cannot make any claim of efficacy, only on body structure or fu ...
... Declared botanical products cannot be removed from the market if they make no health claims and are not proven unsafe * Burden of proof of safety lies with FDA, not manufacturer (unlike prescription drugs) Determined herbal products cannot make any claim of efficacy, only on body structure or fu ...
Medicinal Plants
... developed extracts from effective plants, and those extracts are (though many are now synthesized, rather than extracted) the basis of modern treatments. Example 1: William Withering made the association between a folk remedy of foxglove and its success in treating congestive heart failure in 1775. ...
... developed extracts from effective plants, and those extracts are (though many are now synthesized, rather than extracted) the basis of modern treatments. Example 1: William Withering made the association between a folk remedy of foxglove and its success in treating congestive heart failure in 1775. ...
Diphenhydramine (benadryl): Important Patient Information
... pregnant, or are currently breastfeeding ...
... pregnant, or are currently breastfeeding ...
Dolutegravir (Tivicay )
... Dolutegravir may interact with other medicines. Drug interactions can stop your treatment from working or may cause unwanted side effects. Always tell your pharmacist or doctor if you are using: ...
... Dolutegravir may interact with other medicines. Drug interactions can stop your treatment from working or may cause unwanted side effects. Always tell your pharmacist or doctor if you are using: ...
“Legal highs” in Romania: historical and present facts
... brandy – as the poet Vasile Alecsandri suggestively describes it)[3], which causes an exponential growth of the effects of alcohol, but may also give dependence – particularly psychological – on the overadded hallucinogens. Let us not forget that drinking laudanum (tincture of opium) was already cus ...
... brandy – as the poet Vasile Alecsandri suggestively describes it)[3], which causes an exponential growth of the effects of alcohol, but may also give dependence – particularly psychological – on the overadded hallucinogens. Let us not forget that drinking laudanum (tincture of opium) was already cus ...
Toxicity and safety of medicinal plants
... approach. The use of herbs does not generally involve “drug” actions or adverse effects. Of course, informed knowledge of the effects of medicinal plants as well as doing a clinical trial to understand the appropriate medical application is necessary. It has been suggested that we use the terms indi ...
... approach. The use of herbs does not generally involve “drug” actions or adverse effects. Of course, informed knowledge of the effects of medicinal plants as well as doing a clinical trial to understand the appropriate medical application is necessary. It has been suggested that we use the terms indi ...
new drug driving rules
... able to distinguish using a preliminary saliva test between a driver taking cannabis and a driver taking Sativex. Therefore patients treated with Sativex are likely to give a positive preliminary saliva result and might subsequently be over the specified blood limit. However, if you are an MS suffer ...
... able to distinguish using a preliminary saliva test between a driver taking cannabis and a driver taking Sativex. Therefore patients treated with Sativex are likely to give a positive preliminary saliva result and might subsequently be over the specified blood limit. However, if you are an MS suffer ...
ZYBAN - Action on Smoking and Health
... medicines, either those prescribed by your doctor or those bought without a prescription. ...
... medicines, either those prescribed by your doctor or those bought without a prescription. ...
Kishore Herbstman
... In December 2008, the US Food and Drug Administration issued a new draft Guidance for Industry on Diabetes Mellitus—evaluating cardiovascular risk in new antidiabetic therapies to treat Type 2 diabetes. This guidance comes at a time when recent discussions have focused on delineation of cardiovascul ...
... In December 2008, the US Food and Drug Administration issued a new draft Guidance for Industry on Diabetes Mellitus—evaluating cardiovascular risk in new antidiabetic therapies to treat Type 2 diabetes. This guidance comes at a time when recent discussions have focused on delineation of cardiovascul ...
Take Meds Faithfully - Consumer Reports Health
... you to do so. Don’t be reluctant. Ask yourself: would I rather be embarrassed to tell a doctor that I can’t afford a drug or risk my health because I can’t bring it up? Also, be honest and open with your doctor about any fears you have and any lifestyle issues that could be obstacles to taking a dru ...
... you to do so. Don’t be reluctant. Ask yourself: would I rather be embarrassed to tell a doctor that I can’t afford a drug or risk my health because I can’t bring it up? Also, be honest and open with your doctor about any fears you have and any lifestyle issues that could be obstacles to taking a dru ...
(off-label) and without (unlicensed)
... monitoring the effects of the drug. For off-label prescribing, monitoring can be delegated to another doctor, but not if the drug is completely unlicensed.12 Non-medical prescribers should ensure that they are familiar with their own profession’s prescribing standards, e.g. NMC. Although the advice ...
... monitoring the effects of the drug. For off-label prescribing, monitoring can be delegated to another doctor, but not if the drug is completely unlicensed.12 Non-medical prescribers should ensure that they are familiar with their own profession’s prescribing standards, e.g. NMC. Although the advice ...
A Brief Case against "Omics" and "Precision Medicine
... medical schools, defective genes and/or defective gene products generally result in dysfunction and disease. While some defects are either mild or completely subclinical, many others are - sooner or later - a danger to health and life. The misappropriation of this science, ripe for pharmacoeconomic ...
... medical schools, defective genes and/or defective gene products generally result in dysfunction and disease. While some defects are either mild or completely subclinical, many others are - sooner or later - a danger to health and life. The misappropriation of this science, ripe for pharmacoeconomic ...
www.massbio.org
... This would impede investment, and entry of competition This is not consistent with the greater number of patents covering the making, using and selling of biologics Drugs have greater competition during their patent lives and less earning potential due to the more limited scope of patent cover ...
... This would impede investment, and entry of competition This is not consistent with the greater number of patents covering the making, using and selling of biologics Drugs have greater competition during their patent lives and less earning potential due to the more limited scope of patent cover ...
Slides
... • Why does someone need twice the standard dose to be effective? • Why does this drug work for you but not me? • Why do I have side-effects and you don’t? • Why do some people get cancer and others don’t? • Why is anecdotal information irrelevant to your own health and treatment? ...
... • Why does someone need twice the standard dose to be effective? • Why does this drug work for you but not me? • Why do I have side-effects and you don’t? • Why do some people get cancer and others don’t? • Why is anecdotal information irrelevant to your own health and treatment? ...
vol.13 No.2 - TU Teaching Hospital
... CYP3A4, has a similar level of reported interactions. Azithromycin is considered to have little potential for interactions but of the 111 reports received to ADRAC for this drug, 6 have described interactions with either warfarin or tacrolimus. ...
... CYP3A4, has a similar level of reported interactions. Azithromycin is considered to have little potential for interactions but of the 111 reports received to ADRAC for this drug, 6 have described interactions with either warfarin or tacrolimus. ...
Valerian Tincture
... years later, Galen prescribed valerian for insomnia. Its odour obviously did not repulse everyone since it was used as a spice and perfume in the Middle ages. It was prized for its sedative and calming qualities in the 18th century. In the 19th century, it was used to treat all types of feminine pr ...
... years later, Galen prescribed valerian for insomnia. Its odour obviously did not repulse everyone since it was used as a spice and perfume in the Middle ages. It was prized for its sedative and calming qualities in the 18th century. In the 19th century, it was used to treat all types of feminine pr ...
Alcohol & Prescription drugs
... alcohol with some medicines can lead to falls and serious injuries. It also can put you at risk for internal bleeding, heart problems, and difficulties in breathing. In addition to these dangers, alcohol can make a medication less effective or even useless, or it may make the medication harmful or t ...
... alcohol with some medicines can lead to falls and serious injuries. It also can put you at risk for internal bleeding, heart problems, and difficulties in breathing. In addition to these dangers, alcohol can make a medication less effective or even useless, or it may make the medication harmful or t ...
Patent medicine
A patent medicine is a product that is promoted and sold as a medical cure, but that does not provide the promised relief. Patent medicine is a misnomer because, although the product might be trademarked, it is not patented (the patenting process requires proof that the product does something useful). In ancient times, the term was nostrum remedium (""our remedy"" in Latin).Patent medicines were one of the first major product categories that the advertising industry promoted; patent medicine promoters pioneered many advertising and sales techniques later used for other products.Patent medicine advertising often promoted the advantages of exotic ingredients, which the products seldom contained. For example, sellers of liniments claimed to contain snake oil and falsely promoted as a medical panacea – made the snake oil salesman a lasting symbol for a charlatan.